polypid
participate
three
upcoming
investor
conferences
petah
tikva
israel
globe
newswire
polypid
nasdaq
pypd
phase
biopharmaceutical
company
focused
developing
targeted
locally
administered
therapeutics
using
proprietary
plex
technology
today
announced
present
two
investor
conferences
november
details
presentations
found
company
also
participate
investor
meetings
agp
virtual
healthcare
symposium
thursday
november
wainwright
annual
israel
conference
date
thursday
november
time
pm
eastern
time
stifel
virtual
healthcare
conference
date
tuesday
november
time
eastern
time
webcast
https
webcast
pypd
polypid
polypid
phase
biopharmaceutical
company
focused
developing
targeted
locally
administered
therapeutics
using
proprietary
plex
encapsulation
matrix
technology
polypid
product
candidates
designed
address
diseases
high
unmet
medical
needs
pairing
plex
drugs
deliver
directly
precise
sites
body
predetermined
release
rates
durations
ranging
several
days
several
months
polypid
lead
product
candidate
phase
clinical
trials
prevention
ssis
different
type
surgeries
including
abdominal
surgery
polypid
technology
products
based
inventions
noam
emanuel
founder
chief
scientific
officer
company
additional
company
information
visit
statements
press
release
statements
within
meaning
private
securities
litigation
reform
act
securities
laws
words
expects
anticipates
intends
plans
believes
seeks
estimates
similar
expressions
variations
words
intended
identify
statements
example
company
using
statements
discusses
statements
relating
objectives
plans
strategies
expected
timing
trials
research
development
use
platform
technologies
technologies
products
product
candidates
statements
statements
historical
facts
address
activities
events
developments
company
intends
expects
projects
believes
anticipates
may
occur
future
statements
historical
facts
based
upon
management
current
expectations
beliefs
projections
many
nature
inherently
uncertain
expectations
beliefs
projections
expressed
good
faith
however
assurance
management
expectations
beliefs
projections
achieved
actual
results
may
differ
materially
expressed
indicated
statements
statements
subject
risks
uncertainties
could
cause
actual
performance
results
differ
materially
expressed
statements
detailed
description
risks
uncertainties
affecting
company
reference
made
company
reports
filed
time
time
securities
exchange
commission
sec
including
limited
risks
detailed
company
registration
statement
filed
pursuant
rule
b
filed
sec
june
statements
speak
date
statements
made
company
assumes
obligation
update
statements
reflect
actual
results
subsequent
events
circumstances
changes
assumptions
changes
factors
affecting
information
except
extent
required
applicable
securities
laws
company
update
one
statements
inference
drawn
company
make
additional
updates
respect
thereto
respect
statements
company
contact
polypid
dikla
czaczkes
akselbrad
evp
cfo
tel
investor
contact
bob
yedid
lifesci
advisors
